Pesquisas alternativas:
after forced » after focal (Expandir a Pesquisa), after food (Expandir a Pesquisa)
after forced » after focal (Expandir a Pesquisa), after food (Expandir a Pesquisa)
1
“... unaffected by oxytocin, and the temporal summation protocol failed to show summation before or after drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Publicado no Invest New Drugs (2019)
Assuntos:
“...Phase II Studies...”Publicado no Invest New Drugs (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por van de Putte, L B A, Atkins, C, Malaise, M, Sany, J, Russell, A, van Riel, P L C M, Settas, L, Bijlsma, J, Todesco, S, Dougados, M, Nash, P, Emery, P, Walter, N, Kaul, M, Fischkoff, S, Kupper, H
Publicado em 2004
“...Objective: To evaluate the efficacy and safety of monotherapy with adalimumab in patients with RA...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Burmester, Gerd R, Feist, E, Kellner, H, Braun, J, Iking-Konert, C, Rubbert-Roth, A
Publicado em 2010
“...OBJECTIVES: To confirm the effectiveness and safety of the interleukin 6-receptor antagonist...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Gotfried, Mark H., Girod, Carlos E., Antin-Ozerkis, Danielle, Burgess, Tracy, Strombom, Indiana, Stauffer, John L., Kirchgaessler, Klaus-Uwe, Padilla, Maria L.
Publicado no Pulm Ther (2018)
“...INTRODUCTION: PIPF-002 was a phase 2, multicenter, open-label study of pirfenidone in patients...”Publicado no Pulm Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Manns, M P, Wedemeyer, H, Singer, A, Khomutjanskaja, N, Dienes, H P, Roskams, T, Goldin, R, Hehnke, U, Inoue, H
Publicado em 2012
“...Chronic hepatitis C patients often fail to respond to interferon-based therapies. This phase III...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Yong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, Se-Il Go, Jung Hoon Kim, Seok Jae Huh, Jung Hun Kang, Jun Ho Ji
Publicado em 2022-04-01
“... and safety of a second-line modified dose of FOLFIRINOX (mFOLFIRINOX) for patients who had failed first-line...”Publicado em 2022-04-01
Obter o texto integral
Artigo
8
Por Miller, Robert G., Block, Gilbert, Katz, Jonathan S., Barohn, Richard J., Gopalakrishnan, Vidhya, Cudkowicz, Merit, Zhang, Jane R., McGrath, Michael S., Ludington, Elizabeth, Appel, Stan H., Azhir, Ari
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)
“...OBJECTIVE: To assess the safety, tolerability, and preliminary efficacy of NP001, a novel immune...”Publicado no Neurol Neuroimmunol Neuroinflamm (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Kawasaki, Daizo, Fukunaga, Masashi, Nakata, Tsuyoshi, Kato, Masaaki, Ohkubo, Nobukazu
Publicado no J Atheroscler Thromb (2017)
“... with distal access was applied to 22 lesions after failed antegrade approaches. From July 2016 to December...”Publicado no J Atheroscler Thromb (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Bégin, Philippe, Dominguez, Tina, Wilson, Shruti P, Bacal, Liane, Mehrotra, Anjuli, Kausch, Bethany, Trela, Anthony, Tavassoli, Morvarid, Hoyte, Elisabeth, O’Riordan, Gerri, Blakemore, Alanna, Seki, Scott, Hamilton, Robert G, Nadeau, Kari C
Publicado em 2014
“... protein. OBJECTIVE: To evaluate the safety and dose tolerability of a Phase 1 Single Site OIT protocol...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Tareen, Basir, Summers, Jack L., Jamison, James M., Neal, Deborah R., McGuire, Karen, Gerson, Lowell, Diokno, Ananias
Publicado em 2008
“...Purpose: To evaluate the safety and efficacy of oral Apatone(®) (Vitamin C and Vitamin K(3...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Artigo
12
Por Lee, Choong-kun, Jung, Minkyu, Choi, Hye Jin, Kim, Hye Ryun, Kim, Hyo Song, Roh, Mi Ryung, Ahn, Joong Bae, Chung, Hyun Cheol, Heo, Su Jin, Rha, Sun Young, Shin, Sang Joon
Publicado no Cancer Res Treat (2015)
“... progression after first-line chemotherapy, and platinum-alkylating agents combined with paclitaxel have shown...”Publicado no Cancer Res Treat (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Tao Wang, Weihong Kuang, Wei Chen, Wenwei Xu, Liming Zhang, Yingjie Li, Hailin Li, Ying Peng, Yangmei Chen, Baojun Wang, Jinsong Xiao, Honghua Li, Chuanzhu Yan, Yifeng Du, Mouni Tang, Zhiyi He, Haibo Chen, Wei Li, Hong Lin, Shugui Shi, Jianzhong Bi, Huadong Zhou, Yan Cheng, Xiaoping Gao, Yihui Guan, Qiu Huang, Kewei Chen, Xianliang Xin, Jian Ding, Meiyu Geng, Shifu Xiao
Publicado em 2020-09-01
Assuntos:
“...Safety...”Publicado em 2020-09-01
Obter o texto integral
Artigo
14
Por Mross, Klaus, Büchert, Martin, Frost, Annette, Medinger, Michael, Stopfer, Peter, Studeny, Matus, Kaiser, Rolf
Publicado em 2014
“... signalling, as well as RET and Flt3. The maximum tolerated dose of nintedanib was evaluated in a phase I...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Kipnes, Mark S., Handley, Alison, Lloyd, Eric, Barger, Bruce, Roberts, Andrew
Publicado no J Clin Hypertens (Greenwich) (2015)
“...A phase 3, 26‐week, open‐label, titrate‐to‐target study (n=418) assessed the safety of azilsartan...”Publicado no J Clin Hypertens (Greenwich) (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“... to the emerging field of safety pharmacology. It is concluded that suppression of phase 2 as well as phase 1 VF...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
The efficacy and safety of endovascular recanalization of occluded large cerebral arteries during...
Por Chen, Kangning, Hou, Xianhua, Zhou, Zhenhua, Li, Guangjian, Liu, Qu, Gui, Li, Hu, Jun, Shi, Shugui
Publicado no Stroke Vasc Neurol (2017)
“... with cerebral infarction caused by IAO in the subacute phase. After the procedure, 12 cases were recanalized...”Publicado no Stroke Vasc Neurol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... after the infusion of 100 mL saline. The serological markers tests were used to assess safety and the 28...”
Obter o texto integral
Obter o texto integral
Artigo
19
Por Leichman, Lawrence, Groshen, Susan, O’Neil, Bert H., Messersmith, Wells, Berlin, Jordan, Chan, Emily, Leichman, Cynthia G., Cohen, Steven J., Cohen, Deirdre, Lenz, Heinz-Josef, Gold, Philip, Boman, Bruce, Fielding, Anitra, Locker, Gershon, Cason, Ronald C., Hamilton, Stan R., Hochster, Howard S.
Publicado no Oncologist (2016)
“...-label phase II trial testing olaparib 400 mg p.o. b.i.d. for patients with disseminated, measurable CRC...”Publicado no Oncologist (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por van de Heyning, Paul, Muehlmeier, Guido, Cox, Tony, Lisowska, Grazyna, Maier, Heinz, Morawski, Krzysztof, Meyer, Thomas
Publicado em 2014
“...OBJECTIVE: To evaluate the efficacy and safety of intratympanic AM-101 in patients with persistent...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo